Literature DB >> 22929826

Brugada pattern masquerading as ST-segment elevation myocardial infarction in flecainide toxicity.

Lovely Chhabra1, David H Spodick.   

Abstract

Flecainide (a class 1c antiarrhythmic) produces a dose-dependent decrease in intracardiac conduction. Its well known common electrocardiographic effects are prolongation of PR and QT intervals and the QRS complex duration. We report a case of flecainide toxicity in an elderly female who presented with a type 1 Brugada pattern who essentially had a previously normal ECG pattern on therapeutic dose of flecainide therapy. The case describes a rare electrocardiographic abnormality induced by flecainide toxicity which otherwise could be easily misinterpreted as a ST-segment elevation myocardial infarction (STEMI) without lack of expertise and high clinical suspicion.
Copyright © 2012 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22929826      PMCID: PMC3861284          DOI: 10.1016/j.ihj.2012.06.010

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  9 in total

1.  Does a Brugada pattern ECG precipitated by excessive-dose flecainide provide a diagnosis of a Brugada syndrome patient and/or contraindicate its use? A case study.

Authors:  James A Reiffel
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-08

2.  ST-segment elevation in a patient receiving flecainide.

Authors:  Hangyul Chung-Esaki; Jeffrey Tabas; Nora Goldschlager
Journal:  Arch Intern Med       Date:  2011-01-10

Review 3.  Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.

Authors:  Charles Antzelevitch; Pedro Brugada; Martin Borggrefe; Josep Brugada; Ramon Brugada; Domenico Corrado; Ihor Gussak; Herve LeMarec; Koonlawee Nademanee; Andres Ricardo Perez Riera; Wataru Shimizu; Eric Schulze-Bahr; Hanno Tan; Arthur Wilde
Journal:  Circulation       Date:  2005-01-17       Impact factor: 29.690

4.  ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.

Authors:  A Fujiki; M Usui; H Nagasawa; K Mizumaki; H Hayashi; H Inoue
Journal:  J Cardiovasc Electrophysiol       Date:  1999-02

5.  ST segment elevation in the right precordial leads following administration of class Ic antiarrhythmic drugs.

Authors:  M Yasuda; Y Nakazato; H Yamashita; G Sekita; Y Kawano; Y Mineda; K Nakazato; T Tokano; M Sumiyoshi; Y Nakata
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

6.  Class IC antiarrhythmic drugs, flecainide and pilsicainide, produce ST segment elevation simulating inferior myocardial ischemia.

Authors:  W Nakamura; K Segawa; H Ito; S Tanaka; N Yoshimoto
Journal:  J Cardiovasc Electrophysiol       Date:  1998-08

7.  Brugada electrocardiographic pattern elicited by inadvertent flecainide overdose.

Authors:  Christopher J Hudson; Tanya E Whitner; Michael J Rinaldi; Laszlo Littmann
Journal:  Pacing Clin Electrophysiol       Date:  2004-09       Impact factor: 1.976

Review 8.  Drug-induced Brugada syndrome.

Authors:  Yee Guan Yap; Elijah R Behr; A John Camm
Journal:  Europace       Date:  2009-05-29       Impact factor: 5.214

Review 9.  Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation.

Authors:  Etienne Aliot; Alessandro Capucci; Harry J Crijns; Andreas Goette; Juan Tamargo
Journal:  Europace       Date:  2010-12-07       Impact factor: 5.214

  9 in total
  1 in total

1.  Letter to the Editor in response to "Role of Subcutaneous Leadless Implantable Cardioverter Defibrillator in Young Patients".

Authors:  Nauman Khalid; Pooja Sareen; Sarah Aftab Ahmad; Lovely Chhabra
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.